Brain Natriuretic Peptide EIA Kit
SIGMA/RAB0386 - for serum, plasma, culture supernatant and cell lysates
Synonym: Gamma-brain natriuretic peptide; Natriuretic peptides B ; BNP
Product Type: Chemical
| assay range | inter-assay cv: <15% intra-assay cv: <10% sensitivity: 1.66 pg/mL standard curve range: 0.1–1000 pg/mL |
| detection method | colorimetric |
| input | sample type serum sample type culture supernatant(s) sample type plasma sample type cell lysate |
| packaging | kit of 96 wells (12 strips x 8 wells) |
| shipped in | wet ice |
| species reactivity | human, mouse, rat |
| storage temp. | −20°C |
| technique(s) | ELISA: suitable |
| enzyme immunoassay: suitable |
| Application: | For research use only. Not for use in diagnostic procedures. Brain natriuretic peptide EIA Kit has been used to measure brain natriuretic peptide (BNP) secreted in human neonatal ventricular cardiomyocyte culture. |
| Biochem/physiol Actions: | Brain natriuretic peptide (BNP) expressed in mammalian brain and atrial natriuretic peptide (ANP) facilitates various physiological functions including regulation of blood pressure and cardiac remodeling. BNP acts as a potential biomarker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular (LV) dysfunction. Elevated expression of BNP is observed in acute myocardial infarction (AMI) patients. BNP is also implicated in several biological functions such as diuresis, natriureis, hypotensive action and inhibition of aldosterone secretion. |
| General description: | The BNP Enzyme Immunoassay (EIA) Kit is an in vitro quantitative assay for detecting BNP peptide based on the principle of Competitive Enzyme Immunoassay. |
| Immunogen: | Brain Natriuretic Peptide, synthetic peptide |
| Symbol | GHS05 |
| Signal word | Warning |
| Hazard statements | H290 |
| RIDADR | UN 3264 8 / PGIII |
| WGK Germany | WGK 3 |
| Storage Temp. | −20°C |
| UNSPSC | 41123300 |
| Components | HRP-Streptavidin |

